Drugs / SAR407899A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01485900 | Nov 2011 → Aug 2012 | chronic kidney disease | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR407899A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01485900 ↗ |
| Route | Oral | “Route of administration: oral” NCT01485900 ↗ |